Screener
Emergent Biosolutions EBS Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net income (loss) | $(180.2) | $(12.0) | $(173.4) | $56.0 |
| Earnings (loss) per common share | ||||
| Basic | $(3.49) | $(0.22) | $(3.35) | $1.03 |
| Diluted | $(3.49) | $(0.22) | $(3.35) | $0.99 |
| Weighted average shares outstanding | ||||
| Basic | 51.6 | 54.2 | 51.7 | 54.3 |
| Diluted | 51.6 | 54.2 | 51.7 | 56.7 |
| (1) Exclusive of intangible asset amortization |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Emergent Biosolutions's shares (diluted)?
- Emergent Biosolutions (EBS) reported shares (diluted) of 51.6M in Q2 2026.
- How has Emergent Biosolutions's shares (diluted) changed year-over-year?
- Emergent Biosolutions's shares (diluted) decreased by 4.8% year-over-year, from 54.2M to 51.6M.
- What is the long-term trend for Emergent Biosolutions's shares (diluted)?
- Over 4 years (2021 to 2025), Emergent Biosolutions's shares (diluted) has grown at a 1.0% compound annual growth rate (CAGR), from 216.3M to 224.7M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Emergent Biosolutions's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude